Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
abacavir (ziagen) (1 trial)
efavirenz (sustiva) (1 trial)
isoniazid (nydrazid) (1 trial)
lamivudine (epivir) (1 trial)
lopinavir (Kaletra) (1 trial)
nelfinavir (viracept) (1 trial)
nevirapine (viramune) (1 trial)
ritonavir (Norvir) (1 trial)
trimethoprim (1 trial)
zidovudine (retrovir) (1 trial)
aciclovir (zovirax) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 3)
Herpes Simplex (Phase 2)
HIV Infections (Phase 3)
Infections (Phase 3)
Pneumonia (Phase 3)
Pneumonia, Pneumocystis (Phase 3)
Tuberculosis (Phase 3)
Trials (3 total)
Trial APIs (11 total)